Physician profile
Carol E Miyake
NPI 1760408330
$3,469.82
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,745 · 2020: $1,097 · 2021: $470 · 2022: $158.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $392.17 | 2019-2022 | |
| Glaxosmithkline, LLC. | $364.24 | 2019-2022 | |
| Abbvie INC. | $357.70 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $318.55 | 2019-2021 | |
| Lilly USA, LLC | $233.54 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $231.33 | 2019 | |
| Amgen INC. | $203.91 | 2019-2020 | |
| Corcept Therapeutics | $142.00 | 2019-2020 | |
| Mannkind Corporation | $140.49 | 2019-2021 | |
| Pfizer INC. | $134.49 | 2019-2022 | |
| Abbott Laboratories | $103.81 | 2019-2021 | |
| Mylan Specialty L.P. | $77.59 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $77.09 | 2019-2021 | |
| Ibsa Pharma INC. | $75.14 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $64.82 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $63.60 | 2020 | |
| Radius Health, INC. | $52.14 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.16 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.22 | 2021-2022 | |
| Medtronic Vascular, INC. | $39.35 | 2020 | |
| Dexcom, INC. | $38.15 | 2020 | |
| Xeris Pharmaceuticals, INC. | $37.70 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $31.34 | 2019-2020 | |
| Apria Healthcare LLC | $29.81 | 2021 | |
| Endo Pharmaceuticals INC. | $28.85 | 2020 | |
| Insulet Corporation | $25.19 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.16 | 2019 | |
| Mallinckrodt Enterprises LLC | $18.28 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $18.02 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $15.96 | 2021 | |
| Circassia INC. | $15.42 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.85 | 2020 | |
| Medtronic Minimed, INC. | $12.75 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Miyake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.